Helping Surgeons Treat Their Patients Better® Since 1981
Arthrex, a leader in the biologics market, offers a wide range of innovative, trusted biologic solutions backed by a robust clinical history.
Helping Surgeons Treat Their Patients Better® Since 1981
Arthrex, a leader in the biologics market, offers a wide range of innovative, trusted biologic solutions backed by a robust clinical history.
Revolutionary Advanced Biologics
Comprehensive PRP Solutions
Advanced Microcurrent Technology®
Amniotic Matrices Rich in Growth Factors
Arthrex ACP® System
Learn more arrow_forward
ACP Max™ System
Learn more arrow_forward
Angel® System
Learn more arrow_forward
JumpStart® Antimicrobial Wound Dressing
Learn more arrow_forward
Arthrex Amnion™ Matrix
Learn more arrow_forward
Best-in-class fluid PRF1
INDICATIONS
The Arthrex ACP double-syringe kit is indicated for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of peripheral blood at the patient’s point of care. The PRP is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.
CONTRAINDICATIONS
Contraindications include any active infection or blood supply limitations, as well as previous infections that may delay healing.
ADVERSE EFFECTS
Adverse effects may include infections (both deep and superficial), allergies and other reactions to device materials, hematoma, damage to blood vessels and nerve damage resulting in pain or numbess from autologous sampling, and delayed wound healing.
WARNINGS
Caution: Federal law restricts this device to sale by or on the order of a physician. This device is intended to be used by a trained medical professional. Do not resterilize or reuse the sterile devices.
Follow the manufacturer’s instructions when using the centrifuge and use only benchtop centrifuges with swing-out rotors that securely accommodate Arthrex ACP double-syringes and the ACP Max PRP system (eg, Rotofix 32 A benchtop centrifuge or Drucker Horizon Flex), as outcomes using other types of centrifuges are unknown. Follow the manufacturer’s directions provided with the package insert for the Anticoagulant Citrate Dextrose A Solution (ACD-A).
The safety and effectiveness of this device for bone healing and hemostasis have not been established. The PRP must be used within 4 hours of blood collection. This is a single-use device; reuse could result in device failure and harm to the patient and/or user. Failure to use this device in accordance with the directions for use may result in device failure, render the device unsuitable for its intended use, or compromise the procedure.
The prepared ACD-A anticoagulant and PRP are not for intravenous use; refer to the component label for additional information on ACD-A anticoagulant. Biohazard waste, such as explanted devices, needles, and contaminated surgical equipment, should be safely disposed of in accordance with the institution’s policy.
Serious incidents should be reported to Arthrex, Inc., or an in-country representative, and to the health authority where the incident occurred. Some blood-contacting components of the device have been sterilized with ethylene oxide, which can cause serious allergic reactions in some sensitized individuals.
Highly concentrated PRP containing platelet-derived exosomes8
INDICATIONS
The ACP Max™ platelet-rich plasma (PRP) system is indicated for the safe and rapid preparation of autologous PRP from a small sample of peripheral blood or a small mixture of blood and bone marrow at the patient’s point of care. The PRP is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.
CONTRAINDICATIONS
Contraindications for use include blood supply limitations and previous or active infections, which may delay healing.
ADVERSE EFFECTS
Adverse effects may include infections, both deep and superficial, allergies and other reactions to device materials, hematoma, damage to blood vessels and nerve damage resulting in pain or numbness from autologous sampling, and delayed wound healing.
WARNINGS
Caution: Federal law restricts this device to sale by or on the order of a physician. This device is intended to be used by a trained medical professional. Do not resterilize or reuse the sterile devices.
Follow the manufacturer’s instructions when using centrifuge. Use only benchtop centrifuges with swing-out rotors that securely accommodate Arthrex ACP double-syringes and ACP Max PRP system (eg, Rotofix 32 A benchtop centrifuge or Drucker Horizon Flex). Outcomes using other types of centrifuges are unknown. Follow the manufacturer’s directions that are provided with the package insert for the Anticoagulant Citrate Dextrose A Solution (ACD-A).
The safety and effectiveness of this device for bone healing and hemostasis have not been established. The PRP must be used within four (4) hours of blood collection. This is a single-use device. Reuse of this device could result in failure of the device to perform as intended and could cause harm to the patient and/or user. Failure to use this device in accordance with the directions for use below may result in device failure, render the device unsuitable for its intended use, or compromise the procedure.
ACD-A anticoagulant and PRP prepared are not for intravenous use. For additional information on ACD-A anticoagulant, refer to the component label. Biohazard waste, such as explanted devices, needles, and contaminated surgical equipment, should be safely disposed of in accordance with the institution’s policy.
Serious incidents should be reported to Arthrex, Inc., or an in-country representative, and to the health authority where the incident occurred. Some blood contacting components of the device have been sterilized with ethylene oxide, which can cause serious allergic reactions in some sensitized individuals.
Fully automated, laser-precise cell separation
INDICATIONS
Angel system kits are to be used intraoperatively at the point of care for the safe and rapid preparation of autologous platelet-poor plasma and platelet concentrate (platelet-rich plasma) from a small sample of peripheral blood or a small sample of a mixture of peripheral blood and bone marrow. The platelet-poor and -rich plasmas are mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.
CONTRAINDICATIONS
Contraindications for the use of this device include insufficient quantity or quality of bone, blood supply limitations, and previous infections that may delay healing. Foreign body sensitivity is also a concern; if material sensitivity is suspected, appropriate tests should be conducted to rule out sensitivity prior to implantation.
This device may not be suitable for patients with insufficient or immature bone, and physicians should carefully assess bone quality before performing orthopedic surgery on skeletally immature patients. The use of this medical device and the placement of hardware or implants must not bridge, disturb, or disrupt the growth plate. Additionally, any active infection or blood supply limitations are contraindications.
Conditions that limit the patient’s ability or willingness to restrict activities or follow directions during the healing period should also be considered. Finally, this device should not be used for surgeries other than those indicated.
ADVERSE EFFECTS
Adverse effects may include infections (both deep and superficial), foreign body reactions, and hematoma.
WARNINGS
Caution: Federal law restricts this device to sale by or on the order of a physician, and it is intended to be used by a trained medical professional. Do not resterilize this device. The ABS-10071 Blood Draw Kit’s protective bag is not a sterile barrier; however, the contents of the inner pouches are sterile. Preoperative and operating procedures, including knowledge of surgical techniques and proper selection and placement of the device, are important considerations for successful use. A device labeled as single-use must never be reused, as reuse may pose health and safety risks to the patient, including cross-infection, breakage resulting in irretrievable fragments, compromised mechanical performance due to wear, lack of function, and no guarantee of proper cleaning or sterilization. Biohazard waste, such as explanted devices, needles, and contaminated surgical equipment, should be safely disposed of in accordance with the institution’s policy. Serious incidents should be reported to Arthrex, Inc., or an in-country representative, and to the health authority where the incident occurred.
Accelerated healing and improved cosmetic outcomes for any incision
Placental tissue for natural healing
About Arthrex
Arthrex, Inc., a global leader in multispecialty minimally invasive surgical technology, scientific research, manufacturing, and medical education, is at the forefront of biologics, shaping the future of regenerative medicine.
Each year, we develop more than 1000 new products and related procedures to advance minimally invasive orthopedic, trauma, spine, cardiothoracic, arthroplasty, and aesthetic innovations worldwide. Additionally, Arthrex specializes in the latest 4K multispecialty surgical visualization and OR integration technology solutions. As a leader in medical education, Arthrex technology consultants are committed to supporting you with top-of-the-line service and product expertise.
Our Commitment
Since its inception, Arthrex has been committed to one mission: Helping Surgeons Treat Their Patients Better®.
Arthrex has always remained a privately held company, which allows for the rapid evaluation of new technologies and ideas and the freedom to develop products and techniques that truly make a difference in people’s lives.
The medical significance of our contributions serves as our primary benchmark of success and will continue to be the legacy of Arthrex.
Let us help you start your Arthrex Aesthetics journey.
This is not medical advice and Arthrex recommends that surgeons be trained in the use of a particular product before using it in surgery. A surgeon must always rely on their own professional judgment when deciding whether to use a particular product when treating a particular patient. A surgeon must always refer to the package insert, product label, and/or directions for use before using any Arthrex product. Postoperative management is patient-specific and dependent on the treating professional's assessment. Individual results will vary and not all patients will experience the same postoperative activity level or outcomes. Products may not be available in all markets because product availability is subject to the regulatory or medical practices in individual markets. Please contact Arthrex if you have questions about availability of products in your area. Patient images, videos, and/or testimonials are used with written authorization from the patient.
© 2025 Arthrex, Inc. All rights reserved.